Cardiogenic shock is associated with substantial morbidity and mortality. Although inotropic support is a mainstay of medical therapy for cardiogenic shock, little evidence exists to guide the ...

(UPDATED) A hastily convened collaboration between physicians, pharmacists, and industry experts has pulled together guidance for hospitals and clinicians navigating the US dobutamine shortage that ...

Study Question: What is the effect of a short-term intravenous infusion of levosimendan or dobutamine on long-term survival in acute decompensated heart failure (ADHF)? Methods: The Survival of ...

A scarcity of dobutamine is starting to hit home for cardiologists, surgeons, and patients around the United States, catching some hospitals off guard despite warnings for months that supplies were ...

Patients with cardiogenic shock were assigned to receive milrinone or dobutamine for inotropic support. There was no significant difference between the two groups in the composite primary outcome of ...